New Indications for Ultrasound in the Staging of Cervical Cancer

This study has been withdrawn prior to recruitment.

First Received: March 23, 2007 Last Updated: June 17, 2008 History of Changes

Sponsored by:	Rigshospitalet, Denmark
Information provided by:	Rigshospitalet, Denmark
ClinicalTrials.gov Identifier:	NCT00451945

Purpose

The purpose is to investigate and evaluate two new diagnostic methods using ultrasound in the staging of cervical cancer.

Condition	Intervention
Cervical Cancer	Procedure: biopsy Device: 3d-ultrasound and fusion of UL and PET/CT

MedlinePlus related topics: Cancer Ultrasound

Study Type:	Interventional
Study Design:	Diagnostic, Non-Randomized, Single Blind, Uncontrolled, Single Group Assignment, Efficacy Study
Official Title:	New Indications for Ultrasound in the Staging of Cervical Cancer

Further study details as provided by Rigshospitalet, Denmark:

Study Start Date:	March 2007
Estimated Study Completion Date:	March 2008

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Female

Criteria

Inclusion Criteria:

Exclusion Criteria:

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00451945

Locations

Denmark
Copenhagen univercity hospital, Department of Radiology, section of ultrasound
Copenhagen, Denmark, 2100

Sponsors and Collaborators

Rigshospitalet, Denmark

Investigators

Principal Investigator:

Michael B Nielsen, MDSc

Department of radiology, section of ultrasound

More Information

No publications provided

Study ID Numbers:	H-KF 2007-004
Study First Received:	March 23, 2007
Last Updated:	June 17, 2008
ClinicalTrials.gov Identifier:	NCT00451945 History of Changes
Health Authority:	Denmark: The Danish National Committee on Biomedical Research Ethics

ClinicalTrials.gov processed this record on May 07, 2009